8VC

Arlo Health provides a health benefits platform for small and medium-sized businesses, offering affordable, employee-centric health coverage. The company develops an AI-powered health insurance platform with plan management, concierge support, and predictable renewal rates to help organizations control costs, improve employee satisfaction, and streamline benefits administration.

Tempero Bio is a clinical-stage biopharmaceutical company developing treatments for substance use disorders. Its primary focus is on creating transformative therapies, including an orally available metabotropic glutamate receptor (mGluR5) negative allosteric modulator (NAM), designed to regulate neural signaling and treat conditions such as cocaine and alcohol use disorders.

Latent Labs is a pioneering AI laboratory specializing in programmable biology. It develops advanced generative AI models that capture the core principles of biology, empowering healthcare partners to create novel antibodies, optimize existing enzymes, and advance genetic engineering. This enables partners to gain unparalleled control over molecular biology, driving transformative advancements in health and sustainability.

Founded in San Francisco, Sirona Medical develops a cloud-native platform designed specifically for radiologists. This platform unifies worklist, viewer, reporter, archive, and AI into a single workspace, simplifying complex workflows, enhancing productivity, and empowering practitioners to deliver better, faster care.

SurgLogs Inc. is a software developer based in San Diego, California, specializing in compliance-related solutions for ambulatory surgery centers and healthcare facilities. Founded in 2015, the company provides a digital platform that replaces traditional pen-and-paper methods with a HIPAA-compliant application and an administrative dashboard. This platform organizes and automates the management of logbooks, medications, supplies, in-services, and drills, enhancing efficiency and reducing paperwork for healthcare organizations. SurgLogs offers features such as device authorization, automated daily checks and notifications, and electronic report export services, catering to doctors, nurses, and healthcare administrators. By streamlining compliance processes, SurgLogs enables its clients to maintain regulatory standards effectively and manage operations more efficiently.

Seen Health operates a healthcare service focused on empowering older adults to age with dignity in their communities. It specializes in culturally-focused, technology-enabled services that integrate medical care and social support.

Even partners with top hospitals nationwide to offer unlimited diagnostics, consultations, and hospitalization coverage worth INR 50 lakhs via a single monthly subscription.

Candid Health is a platform that automates revenue cycle management for healthcare providers by integrating with existing infrastructure and using machine learning and artificial intelligence to streamline medical billing, coding, and claims processing. It delivers end-to-end automation to reduce administrative burdens, increase operational efficiency, and accelerate reimbursement, enabling clinics and hospitals to focus more on delivering high-quality, affordable care.

Even partners with top hospitals nationwide to offer unlimited diagnostics, consultations, and hospitalization coverage worth INR 50 lakhs via a single monthly subscription.

Hopscotch Primary Care is a healthcare company focused on transforming rural healthcare through data-driven, team-based care that expands access and improves quality for patients in rural communities. The organization delivers tailored quality care via a collaborative model and provides resources and support for patients inside and outside clinics, enabling clinicians to offer the right care and continuity of service.

Luminate Medical specializes in developing innovative medical devices aimed at preventing hair loss during chemotherapy. Recognizing the significant impact of hair loss on patients' self-esteem, the company focuses on utilizing advanced medical technology to protect this essential element of personality.

Amae Health is a clinic specializing in mental wellness care for individuals with severe mental illnesses. It offers tailored treatments across behavioral medicine, primary care, and social health services, aiming to stabilize patients, enhance their well-being, and prevent future crises. The company's integrated care platform is designed to address the unique needs of its patients, enabling improved health outcomes.

Unlearn.AI, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing innovative software tools for clinical research. Established in 2017, Unlearn.AI focuses on enhancing clinical trials through its unique digital twin technology, known as TwinRCT. This approach utilizes machine learning to create prognostic digital twins for individual patients, allowing for more accurate estimations of treatment effects while reducing the number of participants needed. The company also offers services for Clinical Trial Design, which helps determine inclusion criteria, endpoints, and study sizes, as well as Synthetic Control Arms that can minimize or eliminate the need for concurrent control groups. Additionally, Unlearn.AI provides Subgroup Analysis to identify and analyze specific patient subgroups within trial results. By integrating expertise from pharmaceuticals, medical technology, and machine learning, Unlearn.AI aims to transform clinical trials to improve outcomes for both patients and sponsors.

Founded in 2022, Harbor Health is a multi-specialty clinic group based in Austin, Texas. It offers personalized healthcare through technology, co-creating health paths tailored to individuals' goals with specialist guidance when needed.

Latent Labs is a pioneering AI laboratory specializing in programmable biology. It develops advanced generative AI models that capture the core principles of biology, empowering healthcare partners to create novel antibodies, optimize existing enzymes, and advance genetic engineering. This enables partners to gain unparalleled control over molecular biology, driving transformative advancements in health and sustainability.

Lind AI specializes in AI-driven trial matching for patients. It swiftly and accurately matches patients' medical records with suitable clinical trials, providing comprehensive eligibility evaluations and evidence documentation to healthcare providers. This process aims to expand treatment options for patients across various diseases, from cancer to diabetes, thereby enhancing patient-caregiver connections.

Cellares Corporation, founded in 2019 and based in South San Francisco, California, specializes in the development of cell therapies for cancer treatment. The company addresses significant manufacturing challenges associated with these therapies, which are often produced on a per-patient basis, leading to high costs and limited availability. Cellares is pioneering the Cell Shuttle, an automated, closed end-to-end manufacturing solution designed to enhance the scalability and efficiency of cell therapy production. This innovative system allows for the simultaneous production of ten times more patient doses compared to traditional manual methods, while also reducing process failure rates by three-fold and lowering manufacturing costs by up to 70 percent. By providing flexible and scalable manufacturing options, Cellares aims to accelerate the delivery of life-saving therapies to patients in need and support the broader biopharmaceutical industry in meeting global demand for these treatments.

Endear Health is a technology company focused on addressing the healthcare needs of the aging population. It provides an online platform that serves as a single access point for Medicare-eligible individuals, enabling them to effectively manage their health and benefits. The platform is designed to be user-friendly, offering tools that help seniors collect and organize their health-related information. By doing so, Endear Health aims to empower older adults to overcome barriers in healthcare and take control of their health management.

Vital Bio is focused on transforming lab testing to make healthcare more accessible and personalized. The company develops advanced diagnostic technologies that integrate devices, software, and services to support patients in monitoring their health and managing diseases. By bridging the gap between diagnosis and treatment, Vital Bio aims to empower patients and healthcare providers alike, promoting proactive care and reducing disparities in health outcomes. The company's innovative approach seeks to enhance the overall healthcare experience, ensuring that individuals have greater control over their health management.

Myeloid Therapeutics is an immunology company dedicated to leveraging innovative technologies to harness the potential of myeloid cells for the treatment of cancer and other diseases. The company has developed the ATAK platform, which focuses on reprogramming innate immune cells to enhance their ability to target and eliminate cancerous cells. Initially, Myeloid Therapeutics is advancing a cell therapy program aimed at treating T cell lymphoma, as well as a primed monocyte strategy for glioblastoma. The versatility of the ATAK platform allows for scalability across various treatment modalities and disease areas, facilitating collaboration with partners to expand its applications in the field of immunotherapy.

Nest Health is a family healthcare platform that brings medical services to the home through in-home and virtual visits. It serves patients across newborns, children, teens, and adults with a wide range of services including medical, behavioral health, and nutrition support, as well as preventive care, sick visits, and chronic disease management. The company aims to reduce the burden of arranging care by enabling patients to receive necessary treatments and consultations without leaving home, delivering convenient and accessible care in the familiar setting of the home.

Galileo is a technology company based in New York, founded in 2014, specializing in healthcare solutions. The company offers a mobile application and online communication platform that enables medical professionals to provide comprehensive clinical care directly from their phones. This includes synchronous and asynchronous telecommunications technologies for connecting providers with patients. Galileo's services cater to diverse patient populations, offering high-touch, data-driven, multi-specialty longitudinal care over the phone, at home, and in various settings. The company is recognized by regional and national health plans, employers, and Fortune 500 companies as a leading solution for improving population health.

Elion operates a digital health software marketplace that connects healthcare providers with relevant vendors. Its platform facilitates informed decision-making through comprehensive vendor listings, product evaluations, and educational resources.

SURGE Therapeutics is a biotechnology company focused on enhancing cancer treatment outcomes through innovative immunotherapy solutions. It has developed a proprietary injectable biodegradable hydrogel designed to deliver cancer therapeutics in a prolonged and localized manner. This technology enables targeted release of immunotherapy agents at the surgical site following tumor resection, allowing for more effective treatment administration. By optimizing the timing and location of drug delivery, SURGE Therapeutics aims to improve patient survival rates and minimize systemic side effects, representing a significant advancement in the field of cancer care.

Hexagon Bio, Inc. is a biotechnology company that specializes in discovering novel small molecule therapeutics by mining genomic data from fungal genomes. Founded in 2016 and headquartered in Menlo Park, California, Hexagon Bio leverages a proprietary platform that integrates data science, synthetic biology, and automation to identify and engineer drugs. The company's innovative approach focuses on developing targeted therapies for diseases with unmet medical needs by searching for evolutionarily refined molecules and their associated protein targets. Through its unique methodology, Hexagon Bio aims to uncover new medicines encoded within the global metagenome, ultimately striving to improve patient outcomes.

Our mission is to redefine the standard of care in pulmonary medicine and deliver the best lung care in America. We’re rebuilding the pulmonary clinic around a technology platform and a set of virtual and physical interventions calibrated to keep lung conditions under control. At a Nimbus Clinic, rich patient data and predictive models allow our providers to make more thoughtful medical decisions, and step in at exactly the right moment.

Founded in 2022, Harbor Health is a multi-specialty clinic group based in Austin, Texas. It offers personalized healthcare through technology, co-creating health paths tailored to individuals' goals with specialist guidance when needed.

Digital Diagnostics is a pioneering company developing artificial intelligence-based diagnostic systems for medical images. It offers solutions such as IDx-DR for diabetic retinopathy, IDx-G for glaucoma indicators, and IDx-AMD for age-related macular degeneration detection. The company's autonomous AI platform aims to improve healthcare accessibility, equity, and affordability by making clinical decisions without human intervention.

KeyCare is a virtual care platform that leverages the Epic system to support health systems in enhancing patient access and quality of care. The platform is designed to provide a tech-driven virtual care team that supplements existing healthcare workforces, thereby broadening the options available for virtual care. By focusing on increasing accessibility and improving care quality, KeyCare aims to meet the needs of patients and healthcare providers in a rapidly evolving healthcare landscape.

Cartography Biosciences specializes in developing precision cancer immunotherapies. It employs single-cell analysis to identify novel targets for Chimeric Antigen Receptor T-cell (CAR-T) therapies, aiming to enhance safety and efficacy.

Senti Biosciences is a biotechnology company focused on synthetic biology. It develops gene circuit platforms to engineer therapeutics, with a focus on improving precision and control in cancer treatments.

Amae Health is a clinic specializing in mental wellness care for individuals with severe mental illnesses. It offers tailored treatments across behavioral medicine, primary care, and social health services, aiming to stabilize patients, enhance their well-being, and prevent future crises. The company's integrated care platform is designed to address the unique needs of its patients, enabling improved health outcomes.

Unlearn.AI, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing innovative software tools for clinical research. Established in 2017, Unlearn.AI focuses on enhancing clinical trials through its unique digital twin technology, known as TwinRCT. This approach utilizes machine learning to create prognostic digital twins for individual patients, allowing for more accurate estimations of treatment effects while reducing the number of participants needed. The company also offers services for Clinical Trial Design, which helps determine inclusion criteria, endpoints, and study sizes, as well as Synthetic Control Arms that can minimize or eliminate the need for concurrent control groups. Additionally, Unlearn.AI provides Subgroup Analysis to identify and analyze specific patient subgroups within trial results. By integrating expertise from pharmaceuticals, medical technology, and machine learning, Unlearn.AI aims to transform clinical trials to improve outcomes for both patients and sponsors.

Theia is a pioneering personalized health service tailored specifically for mothers, offering a comprehensive platform that connects them with a network of vetted healthcare professionals. Designed to support women from preconception through early childhood, Theia provides both remote and in-person consultations, ensuring access to holistic care at every stage of motherhood. The platform utilizes data to deliver timely content and advice related to pregnancy, while also facilitating communication with a diverse team of specialists, including psychologists, doctors, and nurses. Theia's commitment to personalized care is underscored by its focus on understanding and respecting each woman's individual needs throughout her journey into motherhood.

Candid Health is a platform that automates revenue cycle management for healthcare providers by integrating with existing infrastructure and using machine learning and artificial intelligence to streamline medical billing, coding, and claims processing. It delivers end-to-end automation to reduce administrative burdens, increase operational efficiency, and accelerate reimbursement, enabling clinics and hospitals to focus more on delivering high-quality, affordable care.

Movet is a veterinary clinic that specializes in providing comprehensive care for pets through both in-person and remote services. The clinic offers general consultations, vaccinations, wound treatments, and surgical procedures, ensuring a wide range of healthcare options for animals. In addition to traditional veterinary services, Movet leverages a telemedicine platform that facilitates remote consultations via chat and video calls, allowing pet owners to access care conveniently. The platform also includes home services such as emergency transfers, delivery of medications, laboratory tests, and diagnostic imaging, enhancing the overall well-being of pets by making veterinary care more accessible.

Endear Health is a technology company focused on addressing the healthcare needs of the aging population. It provides an online platform that serves as a single access point for Medicare-eligible individuals, enabling them to effectively manage their health and benefits. The platform is designed to be user-friendly, offering tools that help seniors collect and organize their health-related information. By doing so, Endear Health aims to empower older adults to overcome barriers in healthcare and take control of their health management.

Ritten specializes in providing an electronic medical records platform tailored for addiction treatment providers. Its platform offers customizable workflow configurations to ensure consistent, compliant care delivery, enabling clinicians and administrators to maintain comprehensive patient records that track clinical notes, medications, and treatment plans, thereby facilitating personalized, data-informed care.

Pair Team provides healthcare coordination services focused on underserved and vulnerable communities. It deploys a dedicated, tech-enabled care team—including community health workers, registered nurses, and behavioral health clinicians—to offer personalized, holistic support to Medicaid and Medicare patients and other low-income individuals facing barriers to care such as transportation, housing and food insecurity, and limited mobile access. The company acts as an extension of safety-net primary care systems, helping them deliver patient-centered care while integrating with community-based organizations. It is building a care delivery platform to standardize clinical practices, streamline administrative tasks, and enable clinicians to spend more time with patients.

SurgLogs Inc. is a software developer based in San Diego, California, specializing in compliance-related solutions for ambulatory surgery centers and healthcare facilities. Founded in 2015, the company provides a digital platform that replaces traditional pen-and-paper methods with a HIPAA-compliant application and an administrative dashboard. This platform organizes and automates the management of logbooks, medications, supplies, in-services, and drills, enhancing efficiency and reducing paperwork for healthcare organizations. SurgLogs offers features such as device authorization, automated daily checks and notifications, and electronic report export services, catering to doctors, nurses, and healthcare administrators. By streamlining compliance processes, SurgLogs enables its clients to maintain regulatory standards effectively and manage operations more efficiently.

Founded in San Francisco, Sirona Medical develops a cloud-native platform designed specifically for radiologists. This platform unifies worklist, viewer, reporter, archive, and AI into a single workspace, simplifying complex workflows, enhancing productivity, and empowering practitioners to deliver better, faster care.

Immunai develops an AI-based immune profiling platform for drug discovery, diagnosis, and treatment. It offers multi-omic single-cell genomics with machine learning algorithms, enabling high-resolution profiling of the immune system at scale. Immunai partners with academic institutions and biopharmaceutical companies to accelerate research and development in immunology.

Better Health is a digital platform facilitating peer-to-peer support and supplies management for individuals with chronic conditions such as ostomy, wounds, diabetes, retention, and incontinence. Trusted by major healthcare payers and providers, it improves patient outcomes and reduces care costs through education, engagement, and adherence.

Elemy is a nationwide provider of childhood behavioral and mental healthcare, specializing in autism care since its launch in April 2020. The company has expanded its services to address a range of developmental and mental health issues, including ADHD, OCD, depression, and social anxiety. Elemy employs a technology-driven care model that modernizes traditional systems by offering in-home and online Applied Behavior Analysis (ABA) services. This approach enhances accessibility and clinical outcomes while reducing costs. The platform features free autism assessments and matches children with therapists to create individualized treatment plans tailored to their specific needs. Elemy's multidisciplinary clinical team oversees an integrated care model, demonstrating significant improvements in behavior for many children.

Melvi is a Brazilian marketplace founded in 2021 by Mariana Paixão, Marcela Sobrinho, and Nino Vashakidze, headquartered in São Paulo. The platform connects patients with clinics, allowing them to easily find and book same-day appointments tailored to their needs at affordable prices. Melvi serves as a resource for patients seeking consultations across various medical specialties, including psychiatry, psychology, and nutrition. Additionally, it enhances clinic occupancy rates by driving a steady volume of new patients. The platform also offers a range of services, including remote consultations and discounted examinations, with convenient online payment options.

Examedi is a healthcare startup that facilitates at-home medical services by connecting patients with independent healthcare providers, including nurses and lab technicians. The company's telemedicine platform allows patients to book diagnostic tests and examinations from the comfort of their homes, focusing on services such as blood tests, pregnancy tests, general check-ups, and COVID-19 testing. By streamlining the scheduling process and offering affordable access to various medical tests, Examedi aims to enhance patient convenience and improve healthcare delivery.

Mindbloom is a mental health and wellness platform that provides at-home, clinician-prescribed psychedelic therapies, including guided ketamine sessions, to help individuals address anxiety and depression and improve overall well-being. The service pairs clients with licensed clinicians who review health history to determine suitability and guide treatment, ensuring physician oversight. The platform combines science-backed medicines designed by psychiatrists with behavioral science-based engagement and personalized media to support personal growth and sustained well-being. Mindbloom serves individual users and enterprise partners, and pursues research collaborations with academic institutions to advance understanding of digital and psychedelic therapies.

Hexagon Bio, Inc. is a biotechnology company that specializes in discovering novel small molecule therapeutics by mining genomic data from fungal genomes. Founded in 2016 and headquartered in Menlo Park, California, Hexagon Bio leverages a proprietary platform that integrates data science, synthetic biology, and automation to identify and engineer drugs. The company's innovative approach focuses on developing targeted therapies for diseases with unmet medical needs by searching for evolutionarily refined molecules and their associated protein targets. Through its unique methodology, Hexagon Bio aims to uncover new medicines encoded within the global metagenome, ultimately striving to improve patient outcomes.

Appia Bio is a biotechnology company dedicated to the research and development of off-the-shelf allogeneic cell therapies, with a particular focus on engineered allogeneic cell therapies for various medical indications. The company utilizes its proprietary ACUA technology platform to harness the biology of lymphocyte development, integrating chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering. This innovative approach allows Appia Bio to generate CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes derived from hematopoietic stem cells (HSCs). By maturing and scaling healthy stem cells into invariant T-cell therapies, Appia Bio aims to provide physicians with safe and targeted cancer treatment options, thereby expanding patient access to advanced therapeutic solutions.

Cellares Corporation, founded in 2019 and based in South San Francisco, California, specializes in the development of cell therapies for cancer treatment. The company addresses significant manufacturing challenges associated with these therapies, which are often produced on a per-patient basis, leading to high costs and limited availability. Cellares is pioneering the Cell Shuttle, an automated, closed end-to-end manufacturing solution designed to enhance the scalability and efficiency of cell therapy production. This innovative system allows for the simultaneous production of ten times more patient doses compared to traditional manual methods, while also reducing process failure rates by three-fold and lowering manufacturing costs by up to 70 percent. By providing flexible and scalable manufacturing options, Cellares aims to accelerate the delivery of life-saving therapies to patients in need and support the broader biopharmaceutical industry in meeting global demand for these treatments.

Seed Health is a biotechnology company focused on therapeutics, consumer health innovations, and environmental solutions grounded in microbial sciences. It collaborates with academic researchers to advance discoveries in microbiology and develops health supplements that employ live biotherapeutics, combining probiotics and prebiotics to support digestive health, skin health, heart health, and micronutrient synthesis.

DocStation, Inc. is a cloud-based patient care platform headquartered in Austin, Texas, that was established in 2017. The company focuses on connecting payers and pharmacists to facilitate value-based care programs, which aim to reduce healthcare costs and enhance patient outcomes. Its platform equips pharmacists with essential tools, including a comprehensive dashboard that consolidates patient information such as diagnoses, medications, immunizations, allergies, and adverse events. This integration allows pharmacists to create care plans, set goals, monitor patient adherence, and schedule follow-ups, thereby enabling real-time connections with patients. With over 500 providers collaborating with innovative health plans on the platform, DocStation is positioned to transform the pharmacy landscape by aligning the interests of all stakeholders involved in patient care.

Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.

Better Health is a digital platform facilitating peer-to-peer support and supplies management for individuals with chronic conditions such as ostomy, wounds, diabetes, retention, and incontinence. Trusted by major healthcare payers and providers, it improves patient outcomes and reduces care costs through education, engagement, and adherence.

Acepodia is a clinical-stage biotechnology company focused on developing innovative, first-in-class cell therapies for cancer treatment. The company utilizes its proprietary Antibody-Cell Conjugation (ACC) platform technology to attach tumor-targeting antibodies directly to immune cell receptors, enhancing the interaction between immune and cancer cells. This approach generates highly specific and potent cell therapies without requiring genetic engineering. Acepodia is dedicated to expanding its research, clinical development, and manufacturing capabilities to provide effective immunotherapeutic strategies against various types of cancer. The company maintains a broad pipeline portfolio, each targeting different cancer indications.

Elemy is a nationwide provider of childhood behavioral and mental healthcare, specializing in autism care since its launch in April 2020. The company has expanded its services to address a range of developmental and mental health issues, including ADHD, OCD, depression, and social anxiety. Elemy employs a technology-driven care model that modernizes traditional systems by offering in-home and online Applied Behavior Analysis (ABA) services. This approach enhances accessibility and clinical outcomes while reducing costs. The platform features free autism assessments and matches children with therapists to create individualized treatment plans tailored to their specific needs. Elemy's multidisciplinary clinical team oversees an integrated care model, demonstrating significant improvements in behavior for many children.

Flywheel.io is a cloud-based data management platform tailored for biomedical research and collaboration. Founded in 2012 and headquartered in Minneapolis, Minnesota, the company provides a suite of tools designed to enhance the workflow of scientists and researchers. Its platform supports medical imaging, scientific computation, and content management, enabling users to capture, manage, and analyze research data efficiently. By utilizing cloud scalability and automation, Flywheel facilitates collaborative research, machine learning applications, and multicenter studies, which help organizations streamline their research processes. The platform, featuring a modern web interface and extensible compute engine, aims to eliminate bottlenecks in innovation, allowing researchers to focus on scientific discovery rather than IT challenges.

Model Medicines employs AI and machine learning to expedite the development of transformative drugs. Its ActivPred AI Drug Discovery Platform identifies repositionable drugs for various diseases, enabling clinical trials within months.

Myeloid Therapeutics is an immunology company dedicated to leveraging innovative technologies to harness the potential of myeloid cells for the treatment of cancer and other diseases. The company has developed the ATAK platform, which focuses on reprogramming innate immune cells to enhance their ability to target and eliminate cancerous cells. Initially, Myeloid Therapeutics is advancing a cell therapy program aimed at treating T cell lymphoma, as well as a primed monocyte strategy for glioblastoma. The versatility of the ATAK platform allows for scalability across various treatment modalities and disease areas, facilitating collaboration with partners to expand its applications in the field of immunotherapy.

Senti Biosciences is a biotechnology company focused on synthetic biology. It develops gene circuit platforms to engineer therapeutics, with a focus on improving precision and control in cancer treatments.

Concerto Biosciences develops microbe-based products that rebuild microbial communities in and around humans and ecosystems. The company uses an ultra-high-throughput platform to experimentally measure millions of microbial interactions and map interaction networks, enabling the discovery of ensembles, which are specific combinations of microbes that work together to shepherd damaged microbial communities back to health. These ensembles have potential applications across medicine and agriculture, addressing global challenges in health, food, and industry. By focusing on microbial community engineering, Concerto aims to become a leading inventor of ensembles and to redefine how microbiomes are leveraged for health and environmental outcomes.

National Resilience, also known as Resilience, is a biopharmaceutical manufacturing and technology company that provides end-to-end manufacturing and development solutions for diverse modalities, including cell and gene therapies, viral vectors, vaccines, and proteins. It actively invests in developing new manufacturing technologies to expand access to complex medicines and supports partners through the full lifecycle from development to commercial supply. The company was incorporated in 2020 and is based in La Jolla, California.

Cellares Corporation, founded in 2019 and based in South San Francisco, California, specializes in the development of cell therapies for cancer treatment. The company addresses significant manufacturing challenges associated with these therapies, which are often produced on a per-patient basis, leading to high costs and limited availability. Cellares is pioneering the Cell Shuttle, an automated, closed end-to-end manufacturing solution designed to enhance the scalability and efficiency of cell therapy production. This innovative system allows for the simultaneous production of ten times more patient doses compared to traditional manual methods, while also reducing process failure rates by three-fold and lowering manufacturing costs by up to 70 percent. By providing flexible and scalable manufacturing options, Cellares aims to accelerate the delivery of life-saving therapies to patients in need and support the broader biopharmaceutical industry in meeting global demand for these treatments.

Dren Bio is a biotechnology company that specializes in protein engineering technologies aimed at depleting pathogenic cells, protein aggregates, and other disease-causing agents. The company operates under a holding business model, developing a diverse portfolio of projects that function as stand-alone assets. Dren Bio's platform is designed to address a range of health conditions, including hematologic neoplasms, solid tumors, autoimmune disorders, and diseases associated with protein aggregation. By focusing on innovative protein-based technologies, Dren Bio enables healthcare professionals to manage and treat various serious diseases more effectively.

Avail Medsystems, Inc. is a digital healthcare company based in Palo Alto, California, that specializes in developing a comprehensive hardware and software platform designed to connect healthcare professionals remotely. The company offers a fully integrated audio/visual system that facilitates real-time collaboration and procedural support, enabling practitioners to access clinical expertise and education without the constraints of physical location. By democratizing access to specialized knowledge and services, Avail Medsystems enhances the efficiency of healthcare delivery and promotes the adoption of innovative medical technologies. Founded in 2012 and previously known as Nurep, Inc., the company aims to improve patient care by bridging gaps between healthcare providers and medical technology experts.

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company based in Woodstock, Georgia, focused on developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, dermatology, animal health, eye care, and oral care. With over 100 products commercialized in 33 countries, Sonoma addresses unmet medical needs through its innovative therapies aimed at chronic skin conditions. Key offerings include Epicyn, an antimicrobial facial cleanser; Levicyn, a prescription product for dermatoses; Celacyn gel for scar management; and SebuDerm for seborrheic dermatitis. Additionally, the company provides Microcyn, which targets various pathogens to promote wound healing, and Acuicyn, designed for eye care. Sonoma Pharmaceuticals was formerly known as Oculus Innovative Sciences, Inc. and has been incorporated since 1999. Its commitment to improving patient care and reducing healthcare costs is reflected in its diverse product portfolio that caters to both prescription and non-prescription needs.

Hexagon Bio, Inc. is a biotechnology company that specializes in discovering novel small molecule therapeutics by mining genomic data from fungal genomes. Founded in 2016 and headquartered in Menlo Park, California, Hexagon Bio leverages a proprietary platform that integrates data science, synthetic biology, and automation to identify and engineer drugs. The company's innovative approach focuses on developing targeted therapies for diseases with unmet medical needs by searching for evolutionarily refined molecules and their associated protein targets. Through its unique methodology, Hexagon Bio aims to uncover new medicines encoded within the global metagenome, ultimately striving to improve patient outcomes.

Founded in San Francisco, Sirona Medical develops a cloud-native platform designed specifically for radiologists. This platform unifies worklist, viewer, reporter, archive, and AI into a single workspace, simplifying complex workflows, enhancing productivity, and empowering practitioners to deliver better, faster care.

Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.

Orca Bio is a clinical-stage cell therapy company focused on providing curative treatments for patients with various malignant and autoimmune diseases. The company has developed a range of proprietary technologies aimed at replacing diseased blood and immune systems with healthy ones. By specializing in the research and development of innovative cell therapies, Orca Bio seeks to transform the landscape of bone marrow transplantation. Its advanced therapeutic platform is designed to empower healthcare professionals in effectively treating patients, thereby addressing a significant unmet medical need. The company is backed by a team of leading experts and technologists committed to realizing its vision of delivering life-saving medical solutions.

Swiftscale Biologics is a healthcare service provider based in South San Francisco, California, founded in 2019. The company specializes in cell-free protein synthesis, focusing on rapid expression, high-throughput synthesis, and the production of complex proteins. Its innovative platform is designed to test and develop antibodies that inhibit the interaction between viral proteins and human host cells, effectively stopping ongoing coronavirus infections. By advancing these life-saving drugs, Swiftscale Biologics aims to enhance patient outcomes and improve overall health.

Mindstrong Health, established in 2013 and based in Mountain View, California, specializes in remote mental health care. It offers a digital therapeutic platform that combines AI-powered technology, data, and clinical expertise to monitor and improve users' mental health. The platform tracks symptoms continuously through passive data collection from human-computer interactions, enabling evidence-based interventions and personalized support. Services include cognitive behavioral therapy, psychoeducation, crisis management, and more, helping thousands of users, including those with serious mental illness.

Octant Bio is a company focused on developing synthetic technology to enhance health and treat diseases. The firm employs synthetic biology, genome engineering, next-generation sequencing, and computational tools to measure the activity of thousands of receptor pathways in human cells simultaneously. This approach allows scientists to use machine learning methods to engineer small molecules that can interact with multiple receptors, offering new potential for treating complex diseases.

Unlearn.AI, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing innovative software tools for clinical research. Established in 2017, Unlearn.AI focuses on enhancing clinical trials through its unique digital twin technology, known as TwinRCT. This approach utilizes machine learning to create prognostic digital twins for individual patients, allowing for more accurate estimations of treatment effects while reducing the number of participants needed. The company also offers services for Clinical Trial Design, which helps determine inclusion criteria, endpoints, and study sizes, as well as Synthetic Control Arms that can minimize or eliminate the need for concurrent control groups. Additionally, Unlearn.AI provides Subgroup Analysis to identify and analyze specific patient subgroups within trial results. By integrating expertise from pharmaceuticals, medical technology, and machine learning, Unlearn.AI aims to transform clinical trials to improve outcomes for both patients and sponsors.

WellPay, Corp. is a healthcare financial technology company that offers a digital platform designed to assist independent medical practices and their patients in managing billing processes. Founded in 2019 and headquartered in San Mateo, California, with additional offices in Raleigh, North Carolina, and Columbia, Maryland, WellPay enables healthcare providers across various sectors—including urgent care, primary care, anesthesiology, dermatology, radiology, obstetrics, psychiatry, sports rehabilitation, and chiropractic—to send and manage bills efficiently. The platform helps billers collect patient balances with real-time reporting and activity management while providing patients with easy-to-understand medical bills and convenient payment options. This modern approach enhances transparency and streamlines the billing experience for both providers and patients.

Candid Health is a platform that automates revenue cycle management for healthcare providers by integrating with existing infrastructure and using machine learning and artificial intelligence to streamline medical billing, coding, and claims processing. It delivers end-to-end automation to reduce administrative burdens, increase operational efficiency, and accelerate reimbursement, enabling clinics and hospitals to focus more on delivering high-quality, affordable care.

SurgLogs Inc. is a software developer based in San Diego, California, specializing in compliance-related solutions for ambulatory surgery centers and healthcare facilities. Founded in 2015, the company provides a digital platform that replaces traditional pen-and-paper methods with a HIPAA-compliant application and an administrative dashboard. This platform organizes and automates the management of logbooks, medications, supplies, in-services, and drills, enhancing efficiency and reducing paperwork for healthcare organizations. SurgLogs offers features such as device authorization, automated daily checks and notifications, and electronic report export services, catering to doctors, nurses, and healthcare administrators. By streamlining compliance processes, SurgLogs enables its clients to maintain regulatory standards effectively and manage operations more efficiently.

Xilis, Inc. is a biotechnology company founded in 2019 and based in Chapel Hill, North Carolina. The company specializes in developing next-generation organoid technologies aimed at guiding precision therapy for cancer patients and enhancing drug discovery processes. Its flagship platform, XilisµO, facilitates rapid diagnostics, personalized drug screening, and the creation of scalable patient-derived models, which support high-throughput drug discovery. By enabling both physicians and pharmaceutical companies to conduct tailored drug screenings, Xilis aims to lower costs and improve treatment outcomes for cancer patients.

Nines is a pioneering teleradiology practice that focuses on enhancing patient care through advanced technology. The company develops in-house tools that empower radiologists to provide high-quality diagnostics. Its platform is designed to analyze medical scans for urgent findings that necessitate immediate attention, as well as to identify subtle details that assist in the radiological review process. This innovative approach aims to improve the accuracy of results and overall patient care, setting Nines apart in the field of radiology.

Eight Sleep is a pioneering sleep technology company that manufactures smart mattresses designed to optimize rest and improve overall health. Founded in 2014, the company's products include temperature-regulating mattresses, sleep trackers, and other accessories aimed at creating personalized, comfortable sleep environments.

ProteinQure is a biotechnology company focused on designing novel exotic peptides with broad therapeutic applications. It leverages quantum computing, atomic-level simulations, reinforcement learning, and artificial intelligence to engineer dynamic peptide therapeutics and to design protein structures with efficiency. The company provides structure determination, protein design, and property determination to enable drug discovery and design. Founded in 2017, ProteinQure is based in Toronto, Canada.

Deciduous Therapeutics is a biotechnology company focused on developing innovative immune-modulatory therapies aimed at addressing age-related diseases. The company specializes in creating novel molecules that activate the body's natural immune surveillance mechanisms to selectively eliminate senescent cells, which are associated with various age-related conditions. Led by Anil Bhushan, a professor at UCSF, and Robin Mansukhani, an experienced biotech entrepreneur, Deciduous Therapeutics is dedicated to promoting a healthier lifespan through its pioneering approach to therapeutics in the aging sector.

Acutus Medical designs, manufactures, and markets tools for catheter-based ablation procedures to treat various cardiac arrhythmias worldwide. Its product portfolio includes access sheaths, transseptal crossing tools, diagnostic catheters, ablation catheters, mapping consoles, and supporting software.

Swiftscale Biologics is a healthcare service provider based in South San Francisco, California, founded in 2019. The company specializes in cell-free protein synthesis, focusing on rapid expression, high-throughput synthesis, and the production of complex proteins. Its innovative platform is designed to test and develop antibodies that inhibit the interaction between viral proteins and human host cells, effectively stopping ongoing coronavirus infections. By advancing these life-saving drugs, Swiftscale Biologics aims to enhance patient outcomes and improve overall health.

Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.

Hims & Hers is a telehealth platform connecting consumers with licensed medical professionals for accessible, convenient healthcare. Initially focused on telemedicine services like erectile dysfunction and hair loss treatments, the company expanded to cover mental health, dermatology, primary care, and more.

Digital Diagnostics is a pioneering company developing artificial intelligence-based diagnostic systems for medical images. It offers solutions such as IDx-DR for diabetic retinopathy, IDx-G for glaucoma indicators, and IDx-AMD for age-related macular degeneration detection. The company's autonomous AI platform aims to improve healthcare accessibility, equity, and affordability by making clinical decisions without human intervention.

Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.

Opencare Inc. is a healthcare discovery platform based in Toronto, Canada, that facilitates connections between patients and healthcare providers across North America. Founded in 2012 and initially known as HealthKiwi Inc., Opencare specializes in the dental sector, creating a premium dental care network that ensures patients receive high-quality care from top dentists. The platform simplifies the process of finding and booking appointments with various healthcare providers, including dentists, chiropractors, massage therapists, physiotherapists, and optometrists. By streamlining interactions between patients and providers, Opencare aims to enhance the overall patient experience in accessing healthcare services.

Notable is an artificial intelligence platform for healthcare operations that automates administrative and operational tasks within health systems, clinics, and other care settings. The platform handles patient intake, scheduling, prior authorization, documentation, and billing automation, enabling providers and staff to streamline workflows and reduce manual workload for more efficient care delivery. It is deployed at over 10,000 sites of care and automates a million repetitive workflows daily across Registration and Intake, Scheduling and Referrals, Assistant, Authorizations, Care Gap Closure, and HCC Chart Review, leading to faster patient processing, improved care coordination, and stronger financial performance for healthcare organizations.

100Plus is a rapidly growing remote patient monitoring platform designed to enhance the management of chronic patients, particularly among the elderly. The company provides an integrated solution that includes patient outreach, device setup, patient engagement, and automatic billing, all without requiring smartphones, apps, Bluetooth, or WiFi. This simplifies the process for both patients and healthcare providers. By delivering fully configured medical devices at no cost to Medicare patients or practices, 100Plus facilitates continuous monitoring of high-risk seniors, enabling healthcare professionals to proactively engage with patients. This approach aims to reduce the need for expensive episodic care and improve overall quality of life for patients.

Oscar Health is a health insurance company based in New York, founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser. It specializes in offering individual and family health insurance plans, Medicare Advantage programs for seniors, and small group products. Oscar Health aims to enhance the healthcare experience by leveraging technology, design, and data to make services more accessible and user-friendly. The company primarily serves individuals, couples, and families who do not receive employer-sponsored health insurance in select states, including New York, New Jersey, California, and Texas. In addition to traditional insurance offerings, Oscar provides virtual care, doctor support, and appointment scheduling, emphasizing a comprehensive approach to healthcare management.

Digital Surgery is a privately-held pioneer in surgical artificial intelligence (AI), data and analytics, and digital education and training.

PathAI, Inc. is a technology company that specializes in developing artificial intelligence solutions for pathology laboratories. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Austin, Texas, PathAI focuses on enhancing the accuracy and efficiency of cancer diagnosis and treatment. The company's platform employs machine and deep learning techniques to analyze large datasets, assisting pathologists in making rapid and precise diagnoses for patients. By addressing complex challenges in pathology, PathAI aims to facilitate personalized medicine and improve patient outcomes by identifying individuals who may benefit from innovative therapies.

Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.

Hexagon Bio, Inc. is a biotechnology company that specializes in discovering novel small molecule therapeutics by mining genomic data from fungal genomes. Founded in 2016 and headquartered in Menlo Park, California, Hexagon Bio leverages a proprietary platform that integrates data science, synthetic biology, and automation to identify and engineer drugs. The company's innovative approach focuses on developing targeted therapies for diseases with unmet medical needs by searching for evolutionarily refined molecules and their associated protein targets. Through its unique methodology, Hexagon Bio aims to uncover new medicines encoded within the global metagenome, ultimately striving to improve patient outcomes.

Blink Health LLC is a digital platform that facilitates the online purchase of prescription medications at lower prices. Founded in 2014 and headquartered in New York, the service allows users to search for their medical prescriptions and either pick them up at local pharmacies across the United States or have them delivered to their homes. By providing access to discounted medications, Blink Health aims to make prescription drugs more affordable and accessible to millions of people. Through its user-friendly web application, the company seeks to streamline the medication purchasing process, enabling customers to save both time and money.

SyntheX specializes in drug discovery using synthetic biology platforms. It identifies protein interaction modulators and enables functional protein degradation, focusing on unique mechanisms for cancer and rare disease treatments.

PathAI, Inc. is a technology company that specializes in developing artificial intelligence solutions for pathology laboratories. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Austin, Texas, PathAI focuses on enhancing the accuracy and efficiency of cancer diagnosis and treatment. The company's platform employs machine and deep learning techniques to analyze large datasets, assisting pathologists in making rapid and precise diagnoses for patients. By addressing complex challenges in pathology, PathAI aims to facilitate personalized medicine and improve patient outcomes by identifying individuals who may benefit from innovative therapies.

Color is a healthcare technology company that offers a comprehensive platform for population health management, facilitating equitable and accessible healthcare delivery. The company specializes in large-scale health initiatives, providing solutions that include population genomics programs and high-throughput testing services, such as those for COVID-19. By centralizing essential healthcare capabilities, Color enables businesses, schools, and state public health departments to implement effective preventive health programs, regardless of the geographical distribution of their populations. Its innovative approach addresses various healthcare logistics challenges, streamlining processes related to testing, screening, treatment, and referrals, while creating diverse market opportunities and revenue streams for clinical teams.